Ezh2 GOF mutation cooperates with BCL2 deregulation (VavP-BCL2, Cγ1cre Ezh2Y641F/wt) to increase the frequency of lymphomas with features of GCB-DLBCL (93, 95). Here, BCL2 is linked to lymphoma.